Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 943 of 1,261
  1. US 8071545

    Therapies and compositions for controlling the stress mechanism and for stabilizing hemostasis in an organism

    Lewis S. Coleman, MD, Inc. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  2. US 8071603

    Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  3. US 8071678

    Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith

    Nektar Therapeutics · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  4. US 8070467

    Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein

    Aphios Corporation · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  5. US 8071084

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  6. US 8071074

    Preventing airway mucus production by administration of EGF-R antagonists

    The Regents of the University of California · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  7. US 8071807

    Antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  8. US 8071618

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  9. US 8071638

    Solid states of atorvastatin potassium

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  10. US 8071692

    Multi-arm block copolymers as drug delivery vehicles

    Nektar Therapeutics · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  11. US 2011293661

    VACCINE STRAINS OF BRACHYSPIRA HYODYSENTERIAE

    HAMPSON DAVID J [AU] · Granted Dec 1, 2011 · Expires Nov 26, 2031

    granted
  12. US 8067416

    Methods and compositions for the treatment of metabolic disorders

    BIOMARIN PHARMACEUTICAL INC. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  13. US 8067417

    Imidazo[1,2-F]pteridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  14. US 8067439

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  15. US 8067237

    Scaffolds for cell transplantation

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  16. US 8067202

    Bacterial superantigen vaccines

    The United States of America as represented by the Secretary of the Army · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  17. US 8067089

    Cationic microcapsule particles

    Appleton Papers Inc. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  18. US 8067219

    Polynucleotide encoding an ATP binding cassette transporter 1 (ABC1) polypeptide

    Xenon Pharmaceuticals Inc. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  19. US 8067355

    Benefit agent containing delivery particles

    Appleton Papers Inc. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  20. US 8066985

    Reovirus for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  21. US 8067473

    Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  22. US 8067563

    Tumor suppressor gene, p471NG3

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  23. US 8067636

    Dihydrazide compounds, preparation and uses thereof

    Bioregen Biomedical (Shanghai) Co., Ltd · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  24. US 8067390

    Therapeutic targeting of interleukins using siRNA in neutral liposomes

    The Board of Regents of the University of Texas System · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.